Skip to main content
. 2019 Jul 31;10:525. doi: 10.3389/fendo.2019.00525

Figure 3.

Figure 3

ROC curve analyses of peak GH after GHRHarg and IGF-I SDS in (A,D) patients with congenital growth hormone deficiency (CGHD, A,D), tumoral GHD (B,E), and (C,F) multiple pituitary hormone deficiency (MPHD).